
AGM/EGM4 Sept 2026, 04:27 pm
Kimia Biosciences to hold 33rd AGM on Sep 28, 2026 via VC
AI Summary
Kimia Biosciences Ltd has announced its 33rd Annual General Meeting (AGM) will be held on September 28, 2026, at 3:00 PM IST. The meeting will be conducted through Video Conferencing/Other Audio Visual Means (VC/OAVM). The company will submit its Annual Report for the financial year 2025-26 along with the AGM notice. The notice and report will be sent electronically to members and will also be available on the company's website, BSE, and NSDL e-Voting platform. The report highlights R&D advancements, including a patent grant for Luliconazole in January 2026.
Key Highlights
- AGM scheduled for September 28, 2026, via video conference.
- Annual Report for FY 2025-26 to be presented.
- Patent granted for antifungal drug Luliconazole in January 2026.
- R&D investments and infrastructure expansion noted.
Price Impact
More from KIMIABL